As European markets navigate mixed economic signals and geopolitical developments, investors are keenly observing opportunities within the region's equity landscape. In this context, identifying stocks priced significantly below their intrinsic value can be a prudent strategy, particularly when market conditions present both challenges and potential growth avenues.
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Tecan Group (SWX:TECN) | CHF196.00 | CHF386.75 | 49.3% |
| Schaeffler (XTRA:SHA0) | €7.02 | €13.84 | 49.3% |
| PSI Software (XTRA:PSAN) | €45.20 | €89.14 | 49.3% |
| Mo-BRUK (WSE:MBR) | PLN398.00 | PLN787.29 | 49.4% |
| Metriks AI. Società Benefit (BIT:MTK) | €3.44 | €6.80 | 49.4% |
| ISS (CPSE:ISS) | DKK284.60 | DKK564.85 | 49.6% |
| Coloplast (CPSE:COLO B) | DKK479.10 | DKK950.93 | 49.6% |
| Borregaard (OB:BRG) | NOK156.40 | NOK310.74 | 49.7% |
| Bonesupport Holding (OM:BONEX) | SEK228.20 | SEK448.88 | 49.2% |
| Acast (OM:ACAST) | SEK34.65 | SEK69.21 | 49.9% |
Let's explore several standout options from the results in the screener.
Overview: Coloplast A/S develops and sells intimate healthcare products and services across Denmark, the United States, the United Kingdom, France, and internationally, with a market cap of DKK107.88 billion.
Operations: The company's revenue segments include Biologics at DKK1.20 billion, Chronic Care at DKK19.38 billion, Interventional Urology at DKK2.88 billion, Advanced Wound Dressings at DKK2.62 billion, and Voice and Respiratory Care at DKK2.36 billion.
Estimated Discount To Fair Value: 49.6%
Coloplast is trading 49.6% below its estimated fair value, presenting a potential undervaluation based on discounted cash flows. Despite recent challenges with profit margins decreasing to 9.7% from 14.6%, the company's earnings are expected to grow significantly at 21.4% annually, outpacing the Danish market's growth rate of 7%. However, its dividend yield of 4.8% is not well covered by earnings, and it maintains a high level of debt.
Overview: FACC AG, along with its subsidiaries, specializes in the development, production, and maintenance of aircraft components globally and has a market cap of €768.36 million.
Operations: The company's revenue is divided into three main segments: Aerostructures (€355.17 million), Cabin Interiors (€496.38 million), and Engines & Nacelles (€174.54 million).
Estimated Discount To Fair Value: 31%
FACC is trading at €16.78, below its estimated future cash flow value of €24.31, indicating potential undervaluation. Earnings are projected to grow significantly at 37.2% annually, surpassing the Austrian market's growth rate of 9.9%. However, recent earnings showed a decline in net income for Q2 compared to last year (€7.98 million vs €9.29 million). Interest payments remain poorly covered by earnings despite strong revenue growth and forecasts for high return on equity (21.7%).
Overview: Mo-BRUK S.A. is involved in the incineration of hazardous waste, such as medical and industrial waste, operating both in Poland and internationally with a market cap of PLN1.40 billion.
Operations: Mo-BRUK S.A.'s revenue is primarily derived from the incineration of hazardous waste, including medical and industrial waste, with operations spanning both domestic and international markets.
Estimated Discount To Fair Value: 49.4%
Mo-BRUK is trading at PLN398, significantly below its estimated future cash flow value of PLN787.29, highlighting potential undervaluation. Recent earnings results show robust growth with sales reaching PLN181.41 million and net income climbing to PLN42.08 million for the half year ended June 2026. Although profit margins have decreased from 22.9% to 8.3%, earnings are forecasted to grow substantially at 30.3% annually, outpacing the Polish market's growth rate of 11%.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com